Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Last week, Ellie Mae ( ELLI - Snapshot Report ) received a contract from LeaderOne Financial, Overland Park, KS for its Encompass360 platform. After thoroughly evaluating a total of nine loan origination systems (LOS), the company finally chose the Encompass360 solution.
David Pearson, chief operating officer and executive vice president of operations for LeaderOne averred that other than the regular features, what provided an edge over other LOS platforms was the advanced controlling along with flexibility, adaptability and reporting ability features of the Encompass360. Apart from this, the Success-Based Pricing model of Ellie Mae ossified faith in the company even more.
Ellie Mae seems well positioned to secure a formidable position in the industry for the time being. On May 2, 2012, the company reported its first quarter financial results of 2012, whereby revenues jumped almost 97% annually to reach $20.9 million for the quarter. It is noteworthy that the number of Encompass users surged 15% year over year to reach a whopping 58,844 by the end of the first quarter. We can remain perspicacious of the company’s Encompass prospects with the current turn of events to behold yet another strong upcoming quarter of 2012.
With its current burgeoning growth trend, the company expects consolidated revenues of 2012 to be within $78 million and $79 million. This denotes a rise of around 40.5% - 42.3% compared to 2011 which is a credible increase for Ellie Mae.
However, it would be wise to be wary of the ominous rivals in the industry at all times. Big players in this regard include The Active Network, Inc. ( ACTV - Snapshot Report ) , Demandware, Inc. ( DWRE - Snapshot Report ) and ExactTarget, Inc. ( ET - Snapshot Report ) .
The company currently retains a Zacks #2 Rank, which translates into a short-term ‘Buy’ rating. We also maintain a long-term ‘Neutral’ recommendation on the stock.
Read the full Snapshot Report on DWRE
Read the full Snapshot Report on ACTV
Read the full Snapshot Report on ELLI
Read the full Snapshot Report on ET